Kuros Biosciences AG/Fr. KURN
08:00
10:05
12:10
14:15
16:20
1D1W1MYTD1Y5YMAX
About Kuros Biosciences AG
Kuros Biosciences AG is a biotechnology company focused on the development and commercialization of novel products for tissue repair and regeneration. The company's portfolio includes biomaterials and biologics aimed at enhancing bone healing in spinal, trauma, and cranio-maxillofacial surgeries. Headquartered in Schlieren, Switzerland, Kuros leverages its proprietary technologies to address unmet clinical needs in bone regeneration. The company's strategic positioning is strengthened by its focus on advanced biomaterial-based solutions, which differentiate its offering in the competitive regenerative medicine market.
Ticker
Fr. KURN
Sector
Primary listing
XSWX
Employees
158
Headquarters
Schlieren, Switzerland
Website
KURN Metrics
BasicAdvanced
CHF 989M
-
-CHF 0.13
0.61
-
Price and volume
Market cap
CHF 989M
Beta
0.61
52-week high
CHF 34.20
52-week low
CHF 14.00
Average daily volume
172K
Financial strength
Current ratio
2.251
Quick ratio
1.679
Long term debt to equity
1.485
Total debt to equity
2.337
Interest coverage (TTM)
0.72%
Profitability
EBITDA (TTM)
5.825
Gross margin (TTM)
88.70%
Net profit margin (TTM)
-5.87%
Operating margin (TTM)
3.73%
Effective tax rate (TTM)
-22.34%
Revenue per employee (TTM)
CHF 650,000
Management effectiveness
Return on assets (TTM)
2.57%
Return on equity (TTM)
-8.62%
Valuation
Price to revenue (TTM)
11.145
Price to book
13.26
Price to tangible book (TTM)
29.17
Price to free cash flow (TTM)
-1,714.208
Free cash flow yield (TTM)
-0.06%
Free cash flow per share (TTM)
-0.015
Growth
Revenue change (TTM)
83.30%
Earnings per share change (TTM)
-54.63%
3-year revenue growth (CAGR)
89.64%
3-year earnings per share growth (CAGR)
-26.18%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Kuros Biosciences AG stock?
Kuros Biosciences AG (KURN) has a market cap of Fr.989M as of February 16, 2026.
What is the P/E ratio for Kuros Biosciences AG stock?
The price to earnings (P/E) ratio for Kuros Biosciences AG (KURN) stock is 0 as of February 16, 2026.
Does Kuros Biosciences AG stock pay dividends?
No, Kuros Biosciences AG (KURN) stock does not pay dividends to its shareholders as of February 16, 2026.
When is the next Kuros Biosciences AG dividend payment date?
Kuros Biosciences AG (KURN) stock does not pay dividends to its shareholders.
What is the beta indicator for Kuros Biosciences AG?
Kuros Biosciences AG (KURN) has a beta rating of 0.61. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.